The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Guardant Health Inc. COM 40131M109 1,569,163 14,037,960 SH   DFND   0 14,037,960 0
Uber Technologies Inc. COM 90353T100 8,106,884 222,228,178 SH   DFND   0 174,320,883 47,907,295
VIR Biotechnology Inc. COM 92764N102 776,430 22,616,666 SH   DFND   0 22,616,666 0
Relay Therapeutics COM 75943R102 1,188,472 27,904,963 SH   DFND   0 27,904,963 0